IRF5 and breast cancer: Additionally, IRF5 downregulation significantly decreased levels of kynurenine (KYN), a tryptophan metabolite, within these breast cancer cells, further supporting the notion that IRF5 modulates breast cancer cell function via regulation of tryptophan metabolism (Fig. 3C).